A detailed history of Page Arthur B transactions in Amgen Inc stock. As of the latest transaction made, Page Arthur B holds 860 shares of AMGN stock, worth $226,506. This represents 0.25% of its overall portfolio holdings.

Number of Shares
860
Previous 910 5.49%
Holding current value
$226,506
Previous $262,000 6.87%
% of portfolio
0.25%
Previous 0.28%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $13,443 - $16,228
-50 Reduced 5.49%
860 $244,000
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $23,013 - $25,961
-90 Reduced 9.0%
910 $262,000
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $11,289 - $13,760
-50 Reduced 4.76%
1,000 $241,000
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $22,446 - $25,315
-100 Reduced 8.7%
1,050 $237,000
Q2 2022

Jul 19, 2022

SELL
$230.71 - $256.74 $80,748 - $89,859
-350 Reduced 23.33%
1,150 $280,000
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $9,944 - $11,380
-50 Reduced 3.23%
1,500 $337,000
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $106,135 - $124,350
-500 Reduced 24.39%
1,550 $330,000
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $29,197 - $32,392
-125 Reduced 5.75%
2,050 $499,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $72,120 - $84,045
-325 Reduced 13.0%
2,175 $541,000
Q3 2020

Oct 28, 2020

SELL
$234.65 - $260.95 $23,465 - $26,095
-100 Reduced 3.85%
2,500 $636,000
Q2 2020

Jul 28, 2020

SELL
$197.81 - $242.74 $39,562 - $48,548
-200 Reduced 7.14%
2,600 $613,000
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $46,653 - $61,875
-256 Reduced 8.38%
2,800 $567,000
Q4 2019

Jan 15, 2020

SELL
$189.21 - $243.2 $68,494 - $88,038
-362 Reduced 10.59%
3,056 $737,000
Q3 2019

Nov 04, 2019

SELL
$174.11 - $208.62 $62,157 - $74,477
-357 Reduced 9.46%
3,418 $661,000
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $25,005 - $29,311
-150 Reduced 3.82%
3,775 $695,000
Q1 2019

Apr 29, 2019

SELL
$180.87 - $203.88 $27,130 - $30,582
-150 Reduced 3.68%
3,925 $746,000
Q3 2018

Oct 15, 2018

SELL
$185.29 - $208.89 $50,954 - $57,444
-275 Reduced 6.32%
4,075 $844,000
Q2 2018

Jul 30, 2018

SELL
$166.05 - $186.51 $41,512 - $46,627
-250 Reduced 5.43%
4,350 $803,000
Q1 2018

Apr 24, 2018

SELL
$169.43 - $198.0 $16,943 - $19,800
-100 Reduced 2.13%
4,600 $784,000
Q4 2017

Feb 02, 2018

SELL
$168.79 - $188.59 $29,538 - $33,003
-175 Reduced 3.59%
4,700 $817,000
Q3 2017

Oct 26, 2017

BUY
$167.29 - $191.0 $815,538 - $931,125
4,875
4,875 $909,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Page Arthur B Portfolio

Follow Page Arthur B and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Page Arthur B, based on Form 13F filings with the SEC.

News

Stay updated on Page Arthur B with notifications on news.